Safety and Pharmacokinetics of BPI-9016M in Patients With Advanced Solid Tumors

NCT02478866 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: BPI-9016M

Sponsor

Betta Pharmaceuticals Co., Ltd.